Random observation: With the positive developments on FTY720, Ipilimumab, and Apixaban in the space of a few days, this past week has to rank as one of the best weeks ever for Big Pharma.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”